Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Fate Therapeutics Inc (NASDAQ:FATE)

2.99
Delayed Data
As of 3:59pm ET
 -0.12 / -3.86%
Today’s Change
1.46
Today|||52-Week Range
4.05
-11.28%
Year-to-Date
No recent news for Fate Therapeutics Inc.

Today’s Trading

Previous close3.11
Today’s open3.13
Day’s range2.71 - 3.25
Volume298,419
Average volume (3 months)254,588
Market cap$106.2M
Dividend yield--
Data as of 3:59pm ET, 12/05/2016

Growth & Valuation

Earnings growth (last year)+7.09%
Earnings growth (this year)+3.39%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales35.33
Price/Book2.35

Competitors

 Today’s
change
Today’s
% change
GNCAGenocea Biosciences ...+0.12+3.18%
VBIVVBI Vaccines Inc-0.13-4.19%
AUPHAurinia Pharmaceutic...+0.15+5.19%
--Wang On Group Ltd0.000.00%
Data as of 3:59pm ET, 12/05/2016

Financials

Next reporting dateMarch 9, 2017
EPS forecast (this quarter)-$0.29
Annual revenue (last year)$2.4M
Annual profit (last year)-$30.0M
Net profit margin-1,233.73%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
J. Scott Wolchko
Chief Scientific Officer
Daniel D. Shoemaker
Corporate headquarters
San Diego, California

Forecasts


Search for Jobs